Top 10 advanced therapy milestones of 2019: Patient access takes center stage
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped Falcon Therapeutics CEO Susan Nichols’ annual roundup. In what has become one of the most anticipated presentations at the Phacilitate conference, Susan Nichols, C ...
The US FDA has issued Indian drugmaker a 483 with five observations following a pre-approval inspection of an API plant in Bangalore.
The US F ...
Bio-Techne, Fresenius Kabi, and Wilson Wolf have partnered to cell and gene therapy developers commercialize their products.
The joint venture ...
Eli Lilly says its injectables pipeline and Trump-era tax laws prompted the decision to build new plant in North Carolina.
Earlier this week L ...
The newly formed Center for Breakthrough Medicines is building what it claims to be the world’s largest third-party cell and gene production fa ...
Recent Tweets
-
RT @Dan5tanton: It's here! Falcon CEO Susan Nichols’ annual roundup of top events within the cell and gene therapy space in 2019, f… https://t.co/qnJkmbuKgi
1 day ago
-
RT @Dan5tanton: And here is the full story from @phacilitate courtesy of @BioProInsider 'CDMO aims ‘big’ in $1.2bn push to deliver… https://t.co/bDTRAi1MIm
5 days ago
-
RT @Dan5tanton: FDA cell and gene therapy forecast ‘unlikely’ - the opinion from Phacilitate #PLW2020 as number of commercialized t… https://t.co/nLyOAHZgtt
6 days ago
-
RT @Dan5tanton: Mixture of pride of advancement but disappointment in relatively few commercial cell and gene products is the feeli… https://t.co/UWblLuPcuq
6 days ago
